Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib effectively treats Alopecia Areata.